(-0.52%) 5 080.75 points
(-0.37%) 38 537 points
(-0.81%) 17 521 points
(-0.14%) $82.69
(-0.12%) $1.651
(-0.01%) $2 338.20
(0.14%) $27.39
(0.17%) $917.40
(-0.24%) $0.932
(-0.33%) $10.95
(-0.40%) $0.799
(-0.10%) $92.23
Quarter results today
(bmo 2024-04-25)
Expected move: +/- 0.00%
-2.41% KRW 34 450
Live Chart Being Loaded With Signals
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids...
Stats | |
---|---|
Today's Volume | 149 655 |
Average Volume | 643 393 |
Market Cap | 1 746.38B |
EPS | KRW0 ( 2024-01-22 ) |
Next earnings date | ( KRW0 ) 2024-07-24 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW53.43 (0.16%) |
Volume Correlation
Hanall Biopharma Co.,Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Hanall Biopharma Co.,Ltd Correlation - Currency/Commodity
Hanall Biopharma Co.,Ltd Financials
Annual | 2023 |
Revenue: | KRW134.91B |
Gross Profit: | KRW73.67B (54.60 %) |
EPS: | KRW69.21 |
Q4 | 2023 |
Revenue: | KRW31.72B |
Gross Profit: | KRW14.26B (44.97 %) |
EPS: | KRW-56.48 |
Q3 | 2023 |
Revenue: | KRW32.97B |
Gross Profit: | KRW17.55B (53.23 %) |
EPS: | KRW6.29 |
Q2 | 2023 |
Revenue: | KRW41.42B |
Gross Profit: | KRW27.20B (65.68 %) |
EPS: | KRW144.14 |
Financial Reports:
No articles found.
Hanall Biopharma Co.,Ltd
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators